Showing results (71-80 of 121) with videos related to
Sort By:
Pageof 13
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 5, 2016
Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosisEiichi Ogawa, Norihiro Furusyo, Naoki Yamashita, et al.BMJ Open|December 22, 2021
Kyushu and Okinawa Population Study (KOPS): a large prospective cohort study in JapanHiroaki Ikezaki, Norihiro Furusyo, Ryoko Nakashima, et al.Journal of Hepatology|August 15, 2012
Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trialNorihiro Furusyo, Eiichi Ogawa, Masayuki Sudoh, et al.World Journal of Hepatology|November 27, 2015
Importance of virological response in the early stage of telaprevir-based triple therapy for hepatitis CSatoshi Hiramine, Norihiro Furusyo, Eiichi Ogawa, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 19, 2020
Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis BEiichi Ogawa, Hideyuki Nomura, Makoto Nakamuta, et al.Journal of Gastroenterology|December 4, 2016
NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1bEiichi Ogawa, Norihiro Furusyo, Hideyuki Nomura, et al.Antiviral Research|October 10, 2018
Elbasvir plus grazoprevir for patients with chronic hepatitis C genotype 1: A multicenter, real-world cohort study focusing on chronic kidney diseaseEiichi Ogawa, Norihiro Furusyo, Koichi Azuma, et al.BMJ Open|June 22, 2019
Cost-effectiveness analysis of sofosbuvir plus ribavirin in patients with genotype 2 chronic hepatitis C: an analysis with real world outcomes from a multicentre cohort in JapanAtaru Igarashi, Norihiro Furusyo, Eiichi Ogawa, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 21, 2015
Efficacy of interferon-beta plus ribavirin combination treatment on the development of hepatocellular carcinoma in Japanese patients with chronic hepatitis CHiroaki Ikezaki, Hideyuki Nomura, Norihiro Furusyo, et al.Journal of Gastroenterology and Hepatology|April 16, 2014
Efficacy and safety of splenectomy in telaprevir-based triple therapy for chronic hepatitis C patients with thrombocytopenia and advanced fibrosisEiichi Ogawa, Norihiro Furusyo, Makoto Nakamuta, et al.Pageof 13